中药抗纤饮治疗慢性乙型肝炎的临床观察  

Clinical Observation on the Treatment of 40 Cases of Chronic Hepatitis B by Kangxianying Soup

作　　者：丁体龙[1] 马勇[1] 李瑞麟[2] 叶根深[2] 涂远航[1] 姜薇薇 

机构地区：[1]中国人民解放军第一二三医院南京军区肝病中心,安徽蚌埠233015 [2]安徽医科大学临床药理研究所安徽省高校省级抗炎免疫药理重点实验室,合肥230032 [3]武警广东总队深圳支队卫生队,深圳518000

出　　处：《中国康复》2007年第3期180-181,共2页Chinese Journal of Rehabilitation

基　　金：南京军区医学科研十五计划项目(02MB019)

摘　　要：目的:观察中药复方制剂——抗纤饮治疗慢性乙型肝炎的临床疗效。方法:慢性乙型肝炎患者80例,随机分为观察组和对照组各40例,均使用保肝、退黄、降酶等药物治疗,观察组加服抗纤饮,每日2次,每次100ml。结果:治疗6个月后,观察组与对照组比较,主要临床症状明显改善,肝功能指标、血清HBV-DNA含量和肝纤维化指标明显降低(P<0.05)。结论:抗纤饮对慢性乙型肝炎有确切的疗效。Objective： To investigate the effectiveness of Kangxianying （KXY） soup in the treatment of chronic hepatitis B （CHB）. Methods： Eighty patients with CHB were divided randomly into treatment group （group A） and control group （group B）. All patients were treated with routine drugs for protecting liver. Additionally, the KXY soup was administered to the patients in group A. The main clinical symptoms, hepatic function, serum HBV-DNA and liver fibro- sis indexes were compared between the two groups. Results： The main clinical symptoms of treatment group were significantly alleviated as compared with those in control group, The level of serum ALT, AST, TBil, HBV-DNA, PCⅢ, LN and HA in treatment group were notably lower than in control group. The liver pathological changes in treatment group were lessened as compared with those in control group. Conclusion： KXY soup is an effective drug to treat CHB.

关 键 词：抗纤饮 乙型肝炎 慢性 

分 类 号：R259[医药卫生—中西医结合]